참고문헌 (23)

1. Buist 203 1985 Inherited Diseases of Amino-acid Metabolism Tyrosinaemia type II 

2. J Inherit Metab Dis Dionisi-Vici 20 suppl 1 15 1997 Tyrosinemia type I with early metastatic hepatocellular carcinoma: Combined treatment with NTBC, chemotherapy and surgical mass removal 

3. Toxicol Appl Pharmacol Ellis 133 12 1995 10.1006/taap.1995.1121 Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione 

   상세보기

4. J Pediatr Gastroenterol Nutr Freese 13 10 1991 10.1097/00005176-199107000-00002 Early liver transplantation is indicated for tyrosinemia type I 

   상세보기

5. J Neurol Neurosurg Psychiatry Gibbs 56 1129 1993 10.1136/jnnp.56.10.1129 Peripheral neuropathy as the presenting feature of tyrosinemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase 

   상세보기

6. Clin Chim Acta Grenier 123 93 1992 10.1016/0009-8981(82)90117-6 Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia 

   상세보기

7. International Pediatrics Holme 10 41 1995 Treatment of tyrosinemia type I with an enzyme inhibitor 

8. Curr Opin Pediatr Holme 7 726 1995 Diagnosis and management of tyrosinemia type I 

   상세보기

9. J Inherit Metab Dis Holme 21 507 1998 10.1023/A:1005410820201 Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione) 

   상세보기

10. Eur J Pediatr Hudak 153 187 1994 10.1007/s004310050119 Evaluation of delta-aminolaevulinic acid excretion in random urine samples of children 

    상세보기

11. Morphometry and electron microscopy J Inherit Metab Dis Kerckaert 20 suppl 1 13 1997 Secondary alterations of hepatic peroxisomes in tyrosinaemia type I 

12. Proc Natl Acad Sci U S A Lindblad 74 4641 1977 10.1073/pnas.74.10.4641 On the enzymic defects in hereditary tyrosinemia 

    상세보기

13. Lancet Lindstedt 340 813 1992 10.1016/0140-6736(92)92685-9 Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase 

    상세보기

14. J Inherit Metab Dis Lock 21 498 1998 10.1023/A:1005458703363 From toxicological problem to therapeutic use: The discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug 

    상세보기

15. Transplantation Luks 56 1376 1993 10.1097/00007890-199312000-00019 Surgical and metabolic aspects of liver transplantation for tyrosinemia 

    상세보기

16. New Engl J Med Mitchell 322 432 1990 10.1056/NEJM199002153220704 Neurologic crises in hereditary tyrosinemia 

    상세보기

17. Eur J Pediatr Mohan 158 suppl 2 S49 1999 10.1007/PL00014321 Indications and outcome of liver transplantation in tyrosinaemia type 1 

    상세보기

18. J Inherit Metab Dis Perez-Cerda 18 119 1995 10.1007/BF00711744 Liver transplantation in nine Spanish patients with tyrosinaemia type I 

    상세보기

19. J Inher Metab Dis Pronicka 19 234 1996 10.1007/BF01799438 Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase (NTBC) 

    상세보기

20. J Inherit Metab Dis van Spronsen 12 suppl 2 339 1989 10.1007/978-94-009-1069-0_45 Tyrosinaemia type I: Orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem 

    

21. Hepatology van Spronsen 20 1187 1994 10.1002/hep.1840200513 Hereditary tyrosinemia type I: A new clinical classification with difference in prognosis on dietary treatment 

    상세보기

22. J Inherit Metab Dis Ros 22 665 1999 10.1023/A:1005594416973 NTBC as palliative treatment in chronic tyrosinaemia type I 

    상세보기

23. J Pediatr Weinberg 88 434 1976 10.1016/S0022-3476(76)80259-4 Occurrence of hepatoma in chronic form of hereditary tyrosinemia 

    상세보기